ALKINDI gran 0.5 mg gélules à ouvrir fl 50 pce
7680682260010
CH-68226
H02AB09
07.07.21
Reimbursement limitations:
ALKINDI
Pour des doses fractionnées ≥5 mg ainsi que pour >3 doses fractionnées par jour, une …
1 / 3
google
Details
- Product number
- 6822601
- CPT
- -
- Packaging group
- 50
- Unit
- Kapsel(n)
- Composition
- hydrocortisonum 0.5 mg, cellulosum microcristallinum, hypromellosum, magnesii stearas, ethylcellulosum ad granulatum pro dosi.
Articles (1)
Alkindi 0.5 mg, Granulat zum Einnehmen
Granulat
50
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 52.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2023
Authorization holder
EffRx Pharmaceuticals SA
8807 Freienbach
Authorization information
- Swissmedic authorization number
- 68226
- Drug name
- Alkindi, Granulat zum Einnehmen
- Galenic form
- GRAO
- ATC Code
- H02AB09
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 21/10/2021
- Authorization expiration date
- 20/10/2026
- IT number
- 07.07.21
- Domain
- Human medicine
Packaging details
- Description (FR)
- ALKINDI gran 0.5 mg gélules à ouvrir fl 50 pce
- Description (DE)
- ALKINDI Gran 0.5 mg Kapseln zum Öffnen Fl 50 Stk
- Market launch
- 21/10/2021
- Narcotic (BTM)
- No